NCT04452266View on ClinicalTrials.gov

Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

October 20, 2020

Study Completion Date

October 20, 2020

Conditions
Lynch Syndrome
Interventions
OTHER

questionnaire assesment

Each patient will to answer questions about their medical history.

Trial Locations (1)

59000

Hôpital Jeanne de Flandres, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT04452266 - Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome | Biotech Hunter | Biotech Hunter